• Saint-Gobain as national and trial counsel in a high-profile environmental toxic tort litigation. Currently defending individual and class action complaints involving medical monitoring and property damages claims in New York, New Hampshire and Vermont.
    • Pfizer as national coordinating counsel in the Lipitor MDL, where 3,000+ plaintiffs alleged that a cholesterol-lowering medication caused them to develop Type 2 diabetes. Dechert’s Daubert strategy led to exclusion of plaintiffs’ experts on general causation grounds and the granting of summary judgment in all cases in the MDL. The Fourth Circuit unanimously affirmed. Dechert subsequently obtained a similar victory in California Superior Court after the product was spun off from Pfizer to Viatris.
    • PFAS: An Evolving Case Study in Environmental Litigation & Regulation - Lawline Webcast (October 26, 2023)